SciELO - Scientific Electronic Library Online

 
vol.27 número3Tratamiento neuroquirúrgico mínimamente invasivo de la neuralgia del trigémino: rizotomia percutánea con balón índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Médica del Uruguay

versión On-line ISSN 1688-0390

Resumen

VAGLIO, Alicia et al. Limitaciones de los estudios de genética molecular en el proceso diagnóstico de fibrosis quística. Rev. Méd. Urug. [online]. 2011, vol.27, n.3, pp.129-137. ISSN 1688-0390.

Summary Introduction: cystic fibrosis is an autosomal recessive hereditary disease caused by mutations of the gene which encodes a protein with a CFTR chloride channel function. It appears as a multi-organ disease and is characterized by a great clinical heterogeneity. There are patients who do not evidence the classic clinical characteristics and are described as atypical or non-classic cystic fibrosis. Diagnosis is based on a consistent clinical phenotype and evidence of dysfunction in the CFTR channel and/or in the identification of two mutations causing cystic fibrosis. None of these definitions is enough in itself to confirm diagnosis. Objectives: to show a few limitations on the molecular genetic studies in the cystic fibrosis diagnostic process Method: five clinical cases of children referred with clinical data of probable cystic fibrosis were considered, and they were requested a genetic study to confirm diagnosis Results: studies conducted do not enable the confirmation of cystic fibrosis diagnosis and neither do they allow discarding a possible diagnosis of atypical cystic fibrosis. Conclusions: in most cases the diagnosis of cystic fibrosis is clear and genetic studies enable the confirmation of diagnosis, genetic counseling and the final prenatal diagnosis. However, use and interpretation of genetic analysis result in several difficulties regarding the clinical and paraclinical characteristics of patients, technical limitations and choosing the mutations to be analysed, especially in the case of atypical cystic fibrosis. The present study shows the challenge faced by clinicians when interpreting a molecular result to incorporate it into the cystic fibrosis diagnostic process.

Palabras clave : CYSTIC FIBROSIS [diagnosis]; CYSTIC FIBROSIS [genetics].

        · resumen en Español | Portugués     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons